Predict your next investment


See what CB Insights has to offer

Founded Year



Acquired | Acquired

About ClearTrial

ClearTrial provides Clinical Trial Operations (CTO) software that makes the planning, forecasting, and tracking of clinical project and financial performance faster and more accurate. The ClearTrial system creates internal and supplier efficiencies and cost savings for biopharmaceutical and medical device customers by integrating clinical operations from Plan to Payment.In March 2012, ClearTrial was acquired by Oracle. The valuation of ClearTrial was undisclosed. Other terms of the deal were not released.

ClearTrial Headquarter Location

328 South Jefferson Street Suite 550

Chicago, Illinois, 60661,

United States


Latest ClearTrial News

Oracle Buys Cloud Based Clinical Trial Application Company-ClearTrial | The Medical Quack

Apr 3, 2012

Oracle Buys Cloud Based Clinical Trial Application Company–ClearTrial It was not too long ago that Oracle Larry Ellison received an award for his contributions to Health IT from the NIH. We see the move with analytics all over healthcare today so this makes sense for Oracle to be in this business. Oracle and Clear Trial will continue to operate as separate companies and biopharmaceutical, device and diagnostic companies are under more pressure than ever today to keep things in a budget for sure. BD   Summary: Oracle plans to combine its analytics resources to ClearTrial’s cloud-based clinical trial operations applications to produce a single, cheaper option for biopharmaceutical and medical device companies. Oracle is beefing up its health sciences suite (and its cloud-based solutions portfolio) with the acquisition of ClearTrial. ClearTrial is a provider of cloud-based clinical trial operations applications intended to facilitate the planning, sourcing, and tracking of clinical projects while ensuring a more accurate and faster financial performance. Its customer base ranges from emerging companies to top-tier biopharmaceutical companies .

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.